Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

3 Apr 2014

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment
Share to Retinoids in leukemia and cellular processes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24695057
DOI: 10.1038/leu.2014.125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patientsPMID 24695057Read ↗

ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia.Semantic proximity Read ↗

Mutations in chronic myelomonocytic leukemia and their prognostic relevance.Semantic proximity Read ↗

Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia.Semantic proximity Read ↗

Genomic Landscape and Risk Stratification in Chronic Myelomonocytic Leukemia.Semantic proximity Read ↗

Prognostic score including gene mutations in chronic myelomonocytic leukemia.Semantic proximity Read ↗

ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia.Semantic proximity Read ↗

Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management.Semantic proximity Read ↗

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.Semantic proximity Read ↗

The biology of chronic myeloid leukemia: an overview of the new insights and biomarkersSemantic proximity Read ↗

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.Semantic proximity Read ↗

Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.Semantic proximity Read ↗

ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study GroupSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.